2026: reflecting on the last year’s research progress and looking at what’s ahead
2025 was one of our most exciting years yet for Parkinson’s research. We saw the launch of EJS ACT-PD, the world’s largest clinical trial for Parkinson’s, the start of recruitment for the phase 3 trial of ambroxol, the forging of new strategic partnerships, and much...
Learn more
Get involved with the Cure Parkinson’s Advocacy Community
At Cure Parkinson’s, the volunteers who are part of our advocacy community play a crucial role in helping support our mission – from shaping research priorities, to sharing their experiences to help raise awareness about living with Parkinson’s. We’d love for you to join us…
Ozzy Osbourne documentary ‘Ozzy: No Escape From Now’ announced
Paramount+ has announced the premiere of a new documentary looking back on the last six years in the life of legendary rock artist Ozzy Osbourne, who lived with Parkinson’s, on 7 October. Directed by BAFTA-award winner Tania Alexander, the feature-length documentary has been produced in…
Pedalling for a cure: fundraisers raise over £30k for Cure Parkinson’s in the 2025 Celtic Challenge
It’s not every day you get to visit the most northerly point in Ireland, let alone cycle through it. Yet for 14 Cure Parkinson’s supporters on Saturday 6 September, the spectacular scenery of Malin Head set the scene for an epic week-long cycling adventure across…
Join the Grand Cru.saders auction and raise funds for Cure Parkinson’s
Members of the Cure Parkinson’s Development Board Barry O’Brien, Malcolm Le May and William Cook have brought together a group of philanthropic wine lovers to join them in raising funds to support Parkinson’s research. They have called themselves the Grand Cru.saders, and are hosting their…
Combination therapies: a change in approach for Parkinson’s research
As part of our research strategy, Cure Parkinson’s is seeking to progress research involving combination therapies as a potential method for targeting Parkinson’s progression. Currently, clinical trials of potentially disease-modifying therapies for Parkinson’s are largely focussed on testing single drugs, or monotherapies. These drugs often…